News Categories
Resources For Living
Mesothelioma Forum
Legal Help Blog
Find a Doctor Near You
About Mesothelioma
Latest News
- Tips For Preventing Mesothelioma or Other Abestos-...
- Certified Cancer Exercise Trainers Available to Me...
- Researcher to Study Cause of Cancer's Resistance t...
- Dynamic Imaging Improves Patient Outcomes in Mesot...
- Hypnosis Can Be Useful for Pain Management in Meso...
- Quick Tips for Enjoying the Holidays when Diagnose...
- Lung Cancer Clinical Trial Matching Service
- American Thoracic Society Provides Patient Informa...
- Canadian Asbestos Abatement Company Celebrates 20-...
- Australia's Asbestos Awareness Week Aims to Raise ...
News Archives
- April 2007
- May 2007
- June 2007
- July 2007
- August 2007
- September 2007
- October 2007
- November 2007
- December 2007
- January 2008
- February 2008
- March 2008
- April 2008
- May 2008
- June 2008
- July 2008
- August 2008
- September 2008
- October 2008
- November 2008
- December 2008
- January 2009
- February 2009
- March 2009
- April 2009
- May 2009
- June 2009
- July 2009
- August 2009
- September 2009
- October 2009
- November 2009
- December 2009
Tuesday, December 1, 2009
The American Association for Cancer Research and the International Association for the Study of Lung Cancer are joining forces to sponsor the conference "Molecular Origins of Lung Cancer: Prospects for Personalized Prevention and Therapy." The conference will be held January 11-14, 2010, at the Loews Coronado Bay Resort in Coronado, California.The program will focus on the latest in lung cancer research and will feature many speakers from the University of Texas M.D. Anderson Cancer Center known throughout the world for their initiatives in the research and treatment of mesothelioma and their focus on personalized medicine.
Steven M. Albelda, M.D, William Maul Measey Professor of Medicine, Vice Chief, Pulmonary, Allergy, and Critical Care Division Director of Lung Research,Co-Director, Thoracic Oncology Laboratories at University of Pennsylvania Medical Center, whose research focuses on the design of new treatment strategies for lung cancer and mesothelioma will present a session entitled: "Personalizing novel mesothelioma treatments by analyzing interferon response pathways."
Additional sessions offered include topics covering:
• Early Detection and Prevention
• Drug Design and New Targets
• Cancer Stem Cells
• Genome-wide Approaches to Risk
• Tumor Profiling
• Lung Biomarkers
• Plus a special session on Advocacy, Regulatory, and Funding Issues
© MesotheliomaHelp.Net. All Rights Reserved. Reprinting or republication of this article or any portion of its content is permitted but must include the MesotheliomaHelp.Net link.
Labels: mesothelioma, Research News
posted by Nancy Meredith at 2:00 PM
